Envelope glycoproteins of human immunodeficiency virus type 1: Profound influences on immune functions

Microbiological Reviews

Volumn 60, Issue 2, 1996, Pages 386-406

  Chirmule, Narendra ^a   Pahwa, Savita ^a  

^a NORTH SHORE UNIVERSITY HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COMPLEMENT; VIRUS ENVELOPE PROTEIN; VIRUS GLYCOPROTEIN;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; APOPTOSIS; B LYMPHOCYTE; CLONAL ANERGY; COMPLEMENT SYSTEM; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNOREGULATION; IMMUNOTHERAPY; MACROPHAGE; NERVE CELL; PROTEIN PROTEIN INTERACTION; REVIEW; T LYMPHOCYTE; THYMOCYTE; VACCINATION; VIRUS ENVELOPE;

EID: 0030008309     PISSN: 01460749     EISSN: None     Source Type: Journal    
DOI: 10.1128/mmbr.60.2.386-406.1996     Document Type: Review

References (437)

1. Akolkar, P., N. Chirmule, B. Gulwani-Akolkar, S. Pahwa, V. S. Kalyanarman, R. Pergolizzi, S. MacPhail, and J. Silver. 1995. Vb specific activation by HIV envelope glycoprotein gp160. Scand. J. Immunol. 41:487-498.
2. Akolkar, P. N., B. Gulwani-Akolkar, N. Chirmule, S. Pahwa, V. S. Kalyanaraman, R. Pergolizzi, S. MacPhail, and J. S. Silver. 1995. The HIV glycoprotein has superantigen-like properties. Clin. Immunol. Immunopathol. 76:255-265.
3. Amadori, A., and L. Chieco-Bianchi. 1990. B cell activation and HIV-1 infection. Deeds and misdeeds. Immunol. Today 11:374-379.
4. + cell function down-regulation in AIDS patients. J. Immunol. 148:2709-2716.
5. Amar, G. O., M. Gilbert, M. Lolly, J. Theze, and D. Jancovic. 1992. IL-4 plays a dominant role in the differential development of Th0 into Th1 and Th2 cells. J. Immunol. 148:3820-3829.
6. Ameglio, F., M. R. Capobianchi, C. Castilletti, P. Cordiali Fei, S. Fais, E. Trento, and F. Dianzani. 1994. Recombinant gp120 induces IL-10 in resting peripheral blood mononuclear cells: correlation with the induction of other cytokines. Clin. Exp. Immunol. 95:455-458.
7. Ameisen, J. C., and A. Capron. 1991. Cell dysfunction and depletion in AIDS: the programmed cell death hypothesis. Immunol. Today 12:102-105.
8. Amendola, A., G. Lombard, S. Oliverio, V. Colizzi, and M. Piacentini. 1994. HIV-1 gp120-dependent induction of apoptosis in antigen-specific human T cell clones is characterized by tissue transglutaminase expression and prevented by cyclosporin A. FEBS Lett. 339:258-264.
9. Amman, A., G. Schiffman, D. Abrams, P. Volberding, J. Ziegler, and M. Conaut. 1984. B cell immunodeficiency in acquired immune deficiency syndrome. JAMA 251:1447-1449.
10. Ardman, B., M. Kowalski, J. Bristol, W. Haseltine, and J. Sodrowski. 1990. Effects on CD4 binding of anti-peptide sera to the fourth and fifth conserved domains of HIV-1 gp120. J. Acquired Immune Defic. Syndr. 3:206-214.
11. Arthos, J., C. K. Deen, M. A. Chaikan, J. A. Fornwald, Q. J. Sattentau, P. R. Clapham, and R. A. Weiss. 1989. Identification of the residues in human CD4 critical for binding of human immunodeficiency virus. Cell 57:469-481.
12. Ascher, M. S., and H. W. Sheppard. 1992. The relationship between AIDS and immunologic tolerance. J. Acquired Immune Defic. Syndr. 5:143-147.
13. Atwood, W. J., J. R. Berger, R. Kaderman, C. S. Tornatore, and E. O. Major. 1993. Human immunodeficiency virus type 1 infection of the brain. Clin. Microbiol. Rev. 6:339-366.
14. Bagnara, G. P., G. Zauli, M. C. Re, G. Furlini, M. Giovannini, S. Ranieri, S. Brizzi, and M. LaPlaca. 1991. Impaired GM-CSF production by cultured light density mononuclear cells and T lymphocytes correlated with the number of circulating CFU-GM in HIV-1 seropositive subjects. Int. J. Cell Cloning 9:239-250.
15. Bahadoran, P., F. R. Laucat, F. Ledeist, S. Blanche, A. Fischer, and J. P. deVillarty. 1993. Lack of selective Vb deletion in peripheral CD4+ T cells of human immunodeficiency virus-infected infants. Eur. J. Immunol. 23:2041-2044.
16. Baldari, C. T., M. M. Di Somma, E. Milia, M. Bergman, and J. T. Telford. 1995. Interactions between the tyrosine kinases p56lck, p59fyn and p50cks signalling in T cells. Eur. J. Immunol. 25:919-925.
17. Baldari, T., E. Milia, M. M. Di Somma, F. Baldoni, S. Valitutti, and J. T. Telford. 1995. Distinct signalling properties identify functionally different CD4 epitopes. Eur. J. Immunol. 25:1843-1850.
18. Baldari, C. T., G. Pelicci, M. M. Di Somma, E. Milia, S. Guili, P. G. Pelicci, and J. T. Telford. 1995. Inhibition of CD4/p56lck signalling by a dominant negative mutant of the She adaptor protein. Oncogene 10:1141-1147.
19. Baldwin, G. C., J. Fleishmann, Y. Chun, Y. Koyonagi, I. S. Chen, and D. W. Golde. 1990. HIV causes mononuclear phagocyte dysfunction. Proc. Natl. Acad. Sci. USA 87:3933-3937.
20. Banda, N. K., J. Bernier, D. K. Kurahara, R. Kurrle, N. Haigwood, R.-P. Sekaly, and T. H. Finkel. 1992. Cross-linking CD4 by HIV gp120 primes T cells for activation induced apoptosis. J. Exp. Med. 176:1099-1106.
21. Bank, I., and L. Chess. 1985. Perturbation of the T4 molecule transmits a negative signal to T cells. J. Exp. Med. 162:1294-1303.
22. Bansal, A. S., L. M. Green, S. H. Khoo, R. S. H. Pumphrey, M. R. Haeney, and B. Mandai. 1993. HIV induces deletion of T cell receptor variable gene product-specific T cells. Clin. Exp. Immunol. 94:17-20.
23. Bansal, A. S., L. M. Green, R. S. H. Pumphrey, and B. Mandai. 1992 T cells, V genes and HIV. Lancet 339:1604.
24. Benkirane, M., M. Hirn, D. Carriere, and C. Devaux. 1995 Functional epitope analysis of human CD4 molecule: antibodies that inhibit human immunodeficiency virus type 1 gene expression bind to the immunoglobulin CDR3-like region of CD4. J. Virol. 69:6898-6903.
25. Benkirane, M., K.-T. Jeang, and C. Devaux. 1994. The cytoplasmic domain of CD4 plays a critical role during the early stages of HIV infection in T cells. EMBO J. 13:5559-5569.
26. Benkirane, M., H. Schmid-Antomarchi, D. R. Littman, M. Hirn, B. Rossl, and C. Devaux. 1995. The cytoplasmic tail of CD4 is required for inhibition of human immunodeficiency virus type 1 replication by antibodies that bind to the immunoglobulin-like region in domain 1 of CD4. J. Virol. 69:6904-6910.
27. + exchange in astrocytes. J. Biol. Chem. 269:13811-13816.
28. Berberian, L., L. Goodlick, T. J. Kipps, and J. Braun. 1993. Immunoglobulin VH3 gene products: natural ligands for HIV gp120. Science 261:1588-1591.
29. Berger, E. A., J. D. Lifson, and L. E. Eiden. 1991. Stimulation of gp120 dissociation from the envelope glycoprotein complex of HIV-1 by soluble CD4 and CD4 peptide derivatives: implications for the role of the CDR3-like region in membrane fusion. Proc. Natl. Acad. Sci. USA 88:8082-8086.
30. Bernstain, H. B., S. P. Tucker, E. Hunter, J. S. Schutzbach, and R. W. Compans. 1994. Human immunodeficiency virus type 1 envelope glycoprotein is modified by O-linked oligosaccharides. J. Virol. 68:463-468.
31. Bernstein, L. J., H. D. Ochs, R. J. Wedgewood, and A. Rubenstein. 1985. Defective humoral immunity in pediatric acquired immunodeficiency syndrome. J. Pediatr. 107:352-360.
32. Bhat, S., R. Mettus, E. Premkumar Reddy, K. E. Ugen, V. Shrkanthan, W. V. Williams, and D. B. Weiner. 1993. The galactosyl ceramide sulphatide receptor binding region of HIV-1 gp120 maps to the amino acids 206-275. AIDS Res. Hum. Retroviruses 88:7131-7134.
33. Bhat, S., S. Spitalnik, F. Gonzalvez-Scrano, and D. H. Sidelberg. 1991. Galactosyl ceramide or a derivative is an essential component of the neural receptor for HIV-1 envelope glycoprotein. gp120. Proc. Natl. Acad. Sci. USA 88:7131-7134.
34. Birx, D. L., R. R. Redfield, K. Tencer, A. Fowler, D. S. Burke, and G. Tosato. 1990. Induction of interleukin 6 during human immunodeficiency virus infection. Blood 76:2303-2310.
35. Bisset, L. R., and A. Feirz. 1992. Areas of sequence homology between several staphylococcal cxotoxins superantigens and HIV-1 pol protein. AIDS Res. Hum. Retroviruses 8:1543-1544.
36. Bollinger, R. C., and R. F. Siliciano. 1993. Immunodeficiency in HIV-1 infection, p. 145-163. In G. P. Wromser (ed.), AIDS and other manifestations of HIV infection. Raven Press, New York.
37. Bonyhadi, M. L., L. Rabin, S. Salimi, D. A. Brown, J. Kokek, J. M. McCune, and H. Kaneshima. 1993. HIV induces thymus depletion in vivo. Nature (London) 363:728-732.
38. Borghi, P., L. Fantuzzi, B. Varano, S. Gessani, P. Puddu, L. Conti, M. Rosario Capobianchi, F. Ameglio, and F. Belardelli. 1995. Induction of interleukin-10 by human immunodeficiency virus type 1 and its gp120 protein in human monocytes/macrophages. J. Virol. 69:1284-1287.
39. Boue, F., C. Wallon, C. Goujard, F. Barre-Sinoussi, P. Galanaud, and J. Delfraissy. 1992. HIV induces IL-6 production by human B lymphocytes: role of IL-4. J. Immunol. 148:3761-3767.
40. Bour, S., R. Geleziunas. and M. A. Wainberg. 1995. The human immunodeficiency virus type 1 (HIV-1) CD4 receptor and its central role in promotion of HIV-1 infection. Microbiol. Rev. 59:63-93.
41. Buyer, V., C. Desgranges, M. A. Trabaud, E. Fischer, and M. D. Kazatchkine. 1991. Complement mediates HIV-1 infection in a human T cell line in a CD4- and antibody-independent fashion. J. Exp. Med. 173:1151-1158.
42. Boyer, V., L. R. Smith, F. Ferre, P. Pezzoli, R. J. Trauger, F. C. Jensen, and D. L. Carlo. 1993. Tcell receptor Vβ repertoire in HIV infected individuals: lack of evidence for selective Vb deletion. Clin. Exp. Immunol. 92:437-441.
43. Breen, E., A. Rezai, K. Nakajima, G. Beall, R. Mitsuyasu, T. Hirano, T. Kishimoto, and O. Martinez-Maza. 1990. Infection with HIV is associated with elevated levels of IL-6 and production. J. Immunol. 144:480-184.
44. Brenneman, D. E., S. K. McCune, R. F. Mervis, and J. M. Hill. 1994. gp120 as an etiologic agent for neuroAIDS: neurotoxicity and model systems. Adv. Neuroimmunol. 4:157-165.
45. Brenneman, D. E., G. L. Westbrook, S. P. Fitzgerald, D. L. Ennist, K. L. Elkins, M. R. Ruff, and C. Pert. 1988. Neuronal killing by the envelope protein of HIV and its prevention by vasoactive intestinal peptide. Nature (London) 335:639-642.
46. Broder, C. C., O. Nussbaum, W. G. Gutheil, W. W. Bachovchin, and E. A. Berger. 1994. CD26 antigen and HIV fusion? Science 264:1156-1159.
47. Brodsky, M. H., M. Worton, R. M. Myers, and D. R. Littman. 1990. Analysis of the site in CD4 that binds to the HIV envelope glycoprotein. J. Immunol. 144:3078-3086.
48. Broker, B. M., A. T. Tsygankov, H. Fichenscher, N. A. Chitaev, I. M. Fleckenstein, B. Fleckenstein, J. B. Bolen, and F. Emmrich. 1994. Engagement of the CD4 receptor inhibits the interleukin 2 dependent proliferation of human T cells transformed by herpesvirus saimiri. Eur. J. Immunol. 24:843-850.
49. + cells. Science 262:2045-2050.
50. Gambier, J. C. 1989. Transmembrane signalling in T-lymphocyte dependent B lymphocyte activation. Semin. Immunol. 1:45-54.
51. + T cells. Science 257:383-387.
52. Capon, D. J., and R. H. Ward. 1991. The CD4-gp120 interactions and AIDS pathogenesis. Annu. Rev. Immunol. 9:649-678.
53. Cayto, A. F., F. Vuiller, J. Siliciano, and G. Dighiero. 1994. Defective protein tyrosine phosphorylation and altered levels of p59fyn and p56lck in CD4 T cells from HIV-1-infected patients. Int. Immunol. 6:611-621.
54. Cefai, D., P. Debre, M. Kaczorek, T. Idzirok, B. Autran, and G. Bismuth. 1990. Human immunodeficiency virus 1 glycoprotein gp120 and gp160 specifically inhibit the CD3/T cell antigen receptor phosphoinositide pathway. J. Clin. Invest. 86:2117-2124.
55. Cefai, D., M. Ferrer, N. Serpente, T. Idziorek, A. Dautry-Varsat, P. Debre, and G. Bismuth. 1992. Internalization of HIV glycoprotein gp120 is associated with down modulation of membrane CD4 p56lck. J. Immunol. 149:285-294.
56. Chanh, T. C., R. C. Kennedy, and P. Kanda. 1988. Synthetic peptides homologous to HIV transmembrane glycoprotein suppress normal human lymphocyte blastogenic response. Cell. Immunol. 111:77-86.
57. Chehimi, J., S. E. Starr, I. Frank, A. D'Andrea, X. Ma, R. R. MacGregor, J. Sennelier, and G. Trincheiri. 1994. Impaired interleukin 12 production in human immunodeficiency virus-infected patients. J. Exp. Med. 179:1361-1366.
58. Chehimi, J., and G. Trincheiri. 1994. Interleukin 12: a bridge between innate resistance and adaptive immunity with a role in infection and acquired immunodeficiency. J. Clin. Immunol. 14:149-161.
59. Cheng-Mayer, C., L. Rutka. M. L. Rosenblum, T. McHugh, D. P. Stiles, and J. A. Levy. 1987. HIV can productively infect cultured human glial cells. Proc. Natl. Acad. Sci. USA 84:3530-3536.
60. Chiodi, F., S. Fuerstenberg, M. Gidlund, B. Asjo, and E. M. Fenjo. 1987. Infection of brain-derived cells with the human immunodeficiency virus. J. Virol. 61:1244-1247.
61. + T cells. J. Biol. Chem. 270:19364-19369.
62. Chirmule, N., V. S. Kalyanaraman, N. Oyaizu, and S. Pahwa. 1988. Inhibitory influences of envelope glycoproteins of HIV-1 on normal immune responses. J. Acquired Immune Defic. Syndr. 1:425-430.
63. Chirmule, N., V. S. Kalyanaraman, N. Oyaizu, H. Slade, and S. Pahwa. 1990. Inhibition of functional properties of tetanus antigen-specific T cell clones by envelope glycoproteins of HIV-1. Blood 75:152-159.
64. Chirmule, N., V. S. Kalyanaraman, and S. Pahwa. 1994. Signals transduced through the CD4 molecule on T lymphocytes activate NF-κB. Biochem. Biophys. Res. Commun. 203:498-505.
65. Chirmule, N., V. S. Kalynaraman, C. Saxinger, J. Ghrayeb, F. Wong-Staal, and S. Pahwa. 1990. Localization of B cell stimulatory activity of HIV-1 to the carboxyl terminal of gp41. AIDS Res. Hum. Retroviruses 6:299-306.
66. Chirmule, N., V. S. Kalyanaraman, H. Slade, N. Oyaizu, and S. Pahwa. 1990. Requirement of T cell receptor for antigen presentation by T lymphocytes: effect of envelope glycoproteins of HIV-1 on antigen presentation by T cells. Clin. Exp. Immunol. 80:161-166.
67. Chirmule, N., T. W. McCloskey, R. Hu, V. S. Kalyanaraman, and S. Pahwa. 1995. HIV gp120 inhibits T cell activation by interfering with expression of costimulatory molecules CD40 ligand and CD80 (B71). J. Immunol. 155:917-924.
68. Chirmule, N., N. Oyaizu, V. S. Kalyanaraman, and S. Pahwa. 1992. Inhibition of normal B cell function by human immunodeficiency virus envelope glycoprotein gp120. Blood 79:1245-1259.
69. Chirmule, N., N. Oyaizu, H. Yagura, M. J. Yellin, V. S. Kalyanarman, S. Lederman, and S. Pahwa. 1993. HIV gp160 induced T cell dependent B cell differentiation. Role of T cell-B cell activation molecule and IL-6. J. Immunol. 150:2478-2486.
70. Chirmule, N., C. Saxinger, N. Oyaizu, and S. Pahwa. 1994. HIV-1 nef has B cell stimulatory activity. AIDS 8:733-739.
71. Chirmule, N., X.-P. Wang, R. Hu, V. S. Kalyanaraman, N. Oyaizu, C. Roifmann, R. Pahwa, and S. Pahwa. 1994. Envelope glycoproteins of HIV-1 interfere with T-cell-dependent B cell differentiation: role of CD4-MHC class II interaction in the effector phase of T cell help. Cell. Immunol. 155:169-182.
72. Chuck, R. S., C. S. Cantor, and D. B. Tse. 1993. Effect of CD4 engagement on CD4-T cell receptor complexes. Cell. Immunol. 152:211-219.
73. Chuvpilo, S., C. Schomberg, R. Gerwig, A. Heinfling, R. Reeves, F. Grummt, and E. Serfling. 1993. Multiple closely-linked NFAT/octamer and HMG I(Y) binding sites are part of the interleukin 4 promoter. Nucleic Acids Res. 21:5692-5704.
74. Cianciolo, G. J., T. D. Copeland, S. Oroszlan, and R. Snyderman. 1985. Inhibition of lymphocyte proliferation by a synthetic peptide homologous to retroviral envelope proteins. Science 230:453-455.
75. Clark, S. J., W. A. Jeffries, A. N. Barklay, J. Gagnoon, and A. F. William. 1987. Peptide and nucleotide sequences of rat CD4 antigen: evidence for derivation from a structure with four immunoglobulin related domains. Proc. Natl. Acad. Sci. USA 84:1649-1653.
76. Clayton, L., R. E. Hussey, R. Steinbrich, H. Ramachandran, Y. Hussain, and E. L. Reinherz. 1988. Substitution of murine and human CD4 residues identifies amino acids critical for HIV-gp120 binding. Nature (London) 335:363-366.
77. Clayton, L. K., M. Seih, D. A. Pios, and E. L. Reinherz. 1989. Identification of human CD4 residues affecting class II MHC versus HIV-1 gp120 binding. Nature (London) 339:548-551.
78. Clerici, M., F. T. Hakim, D. J. Venzon, S. Blatt, C. W. Hendriz, T. A. Wynn, and G. M. Shearer. 1993. Changes in interleukin 2 and interleukin 4 production in asymptomatic human immunodeficiency virus-seropositive individuals. J. Clin. Invest. 91:759-765.
79. Clerici, M., D. R. Lucey, J. A. Berzofsky, L. A. Pinto, T. A. Wynn, S. Blatt, M. J. Dolan, C. W. Hendriz, S. F. Wolf, and G. M. Shearer. 1993. Restoration of HIV-specific cell mediated immune responses by interleukin 12 in vitro. Science 262:1721-1724.
80. Clerici, M., A. Sarin, R. L. Coffman, T. A. Wynn, S. P. Blatt, C. W. Hendrix, S. F. Wolf, G. M. Shearer, and P. A. Henkart. 1994. Type 1/type 2 cytokine modulation of T cell programmed cell death as a model for HIV pathogenesis. Proc. Natl. Acad. Sci. USA 91:11811-11815.
81. Clerici, M., and G. M. Shearer. 1994. The Th1-Th2 hypothesis of HIV infection: new insights. Immunol. Today 15:575-581.
82. Clerici, M., T. A. Wynn, J. A. Berzofsky, S. Blatt, C. W. Hendriz, A. Sher, R. L. Coffmann, and G. M. Shearer. 1994. Role of interleukin 10 in T helper cell dysfunction in asymptomatic individuals infected with the human immunodeficiency virus. J. Clin. Invest. 93:768-775.
83. Clouse, K. A., L. M. Couhitino, K. A. Weih, S. W. Pyle, P. B. Robbins, H. D. Hochstein, V. Natarajan, and W. L. Farrar. 1991. The HIV-1 gp120 envelope protein has the intrinsic capacity to stimulate monokine secretion. J. Immunol. 147:2892-2901.
84. Cohen, D. I., Y. Tani, H. Tian, E. Boone, L. E. Samelson, and H. C. Lane. 1992. Participation of tyrosine phosphorylation in the cytopathic effects of human immunodeficiency virus-1. Science 256:542-545.
85. Connor, R. I., and D. D. Ho. 1992. Pathogenesis of HIV. Semin. Virol. 2:213-224.
86. + T cell activation and adhesion by peptides derived from the gp160. J. Immunol. 147:475-482.
87. + T cells. J. Gen. Virol. 76:681-690.
88. Cordialli, P., V. Baizrotti, S. Morante, V. Parisi, O. Pugilese, B. Campneschi, and V. Colizzi. 1992. Convergent evolution in the homology between HIV gp160 and HLA class II molecules. AIDS Res. Hum. Retroviruses 8:1561-1565.
89. Cougnard, V., F. Laure, A. Bossard, A. Goudeau, F. Barin, and C. Brechot. 1991. Frequent and early in utero HIV-1 infection. AIDS Res. Hum. Retroviruses 7:337-341.
90. lck complex in the endoplasmic reticulum. J. Virol. 66:2296-2301.
91. Crispe, I. N. 1994. Fatal attractions: Fas induced apoptosis in mature T cells. Immunity 1:347-349.
92. Dadaglio, G., S. Garcia, L. Montagnier, and M.-L. Gougeon. 1994. Selective anergy of Vb8+ T cells in human immunodeficiency virus infected individuals. J. Exp. Med. 179:413-424.
93. Dalgleish, A. G., P. C. L. Beverley, P. R. Clapham, D. H. Crawford, M. F. Greaves, R. A. Weiss. 1984. The CD4 (T4) antigen is an essential component of the receptor for the AIDS retrovirus. Nature (London) 213:763-767.
94. Dalgleish, A. G., and V. Colizzi. 1992. Role of major histocompatibility complex recognition in the protection and immunopathogenesis of AIDS. AIDS 6:523-525.
95. Dalgleish, A. G., S. Wilson, M. Gompels, C. Ludlam, B. Gazzard, A. M. Coates, and J. Habeshaw. 1992. T cell receptor variable gene products and early HIV-1 infection. Lancet 339:824-828.
96. Daniel, V., K. Schimpf, and G. Opelz. 1989. Lymphocyte autoantibodies and alloantibodies in HIV-positive hemophilia patients. Clin. Exp. Immunol. 75:178-183.
97. Daniel, V., C. Susal, R. Weimer, R. Zimmerman, A. Huth-Kuhne, and G. Opelz. 1993. Association of T cell and macrophage dysfunction with surface gp120-immunoglobulin-complement complexes in HIV-infected patients. Clin. Exp. Immunol. 93:152-156.
98. Davis, B. R., D. H. Schwartz, J. C. Marx, C. E. Johnson, J. M. Berry, J. Lyding, T. C. Merigan, and A. Zander. 1991. Absent or rare HIV infection of bone-marrow stem/progenitor cells in vivo. J. Virol. 65:1985-1990.
99. Dawson, V. L., T. M. Dawson, G. R. Uhl, and S. H. Snyder. 1993. HIV-1 coat protein neurotoxicity mediated nitric oxide in primary cortical cultures. Proc. Natl. Acad. Sci. USA 90:3256-3259.
100. Del Prete, G., and S. Romagniani. 1994. An alternative view of the Th1/Th2 switch hypothesis in HIV infection. AIDS Res. Hum. Retroviruses 10:iii-ix.
101. deRossi, A., M. Calabro, M. Panozzo, D. Bernardi, B. Caruso, G. Tridente, and L. Chieco-Bianchi. 1990. In vitro studies of HIV-1 infection in thymic lymphocytes: a putative role of the thymus in AIDS pathogenesis. AIDS Res. Hum. Retroviruses 6:287-298.
102. Dhein, J., H. Walczak, C. Baumler, K.-M. Debatin, and P. H. Krammer. 1995. Autocrine T-cell suicide mediated by APO-1 (Fas/CD95). Nature (London) 373:438-441.
103. + T cell function by the HIV envelope protein gp120. J. Immunol. 141:3715-3717.
104. Dianzani, U., M. Bragardo, D. Buonfiglio, V. Redoglia, A. Funara, P. Portoles, J. Rojo, F. Malavasi, and A. Pileri. 1995. Modulation of CD4 lateral interaction with lymphocyte surface molecules induced by HIV-1 gp120. Eur. J. Immunol. 25:1306-1311.
105. Dianzani, U., A. Shaw, M. F. Cabezudo, and C. A. Janeway. 1992. Extensive CD4 cross-linking inhibits T cell activation by anti-receptor antibody but not by antigen. Int. Immunol. 4:995-1001.
106. Dierich, M. P., C. Ebenbichler, P. Marschang, G. Fust, N. Theilens, and G. Arlaud. 1993. HIV and complement: mechanism of interaction and biological implications. Immunol. Today 14:435-440.
107. Dobrescu, D., B. Ursea, M. Pope, A. S. Asch, and D. N. Posnett. 1995. Enhanced HIV-1 replication in Vb12 T cells due to human cytomegalovirus in monocytes: evidence for a putative herpes superantigen. Immunity 82:753-763.
108. Donahue, R. E., M. M. Johnson, L. I. Zon, S. C. Clark, and J. E. Groopeman. 1987. Suppression of in vitro hematopoiesis following HIV infection. Nature (London) 326:200.
109. Drake, C. G., and B. L. Kotzin. 1992. Superantigens: biology, immunology and potential role in disease. J. Clin. Immunol. 12:149-162.
110. Dryer, E. B., P. K. Kaiser, J. T. Offerman, and S. A. Lipton. 1990. HIV coat protein neurotoxicity prevented by calcium channel antagonists. Science 248:364-367.
111. Durrbaum, L. I., E. Kaltenhauser, H. D. Flad, and M. Ernst. 1994. HIV envelope protein gp120 affects phenotype and functions of monocytes in vitro. J. Leukocyte Biol. 55:545-551.
112. Ebenbichler, C., N. Theilens, R. Vornhagen, L. Ratner, and M. Dierich. 1991. HIV-1 activates the classical pathway of complement by direct C1 binding through specific sites in the transmembrane gp41. J. Exp. Med. 174:1417-1424.
113. Ehrenreich, H., P. Rieckmann, F. Sinowatz, K. A. Weih, L. O. Arthur, F.-D. Goebel, P. R. Burd, J. E. Coligan, and K. A. Clouse. 1993. Potent stimulation of monocytic endothelin-1 and production by HIV-1 gp120. J. Immunol. 150:4601-4609.
114. Eiden, L. E., and J. D. Lifson. 1992. HIV interactions with CD4: a continuum of conformations and consequences. Immunol. Today 13:201-206.
115. Embretson, J., M. Zapancic, J. L. Ribas, A. Buke, P. Racz, K. Tenner-Racz, and A. T. Haase. 1993. Massive covert infection of helper T lymphocytes and macrophages by HIV during the incubation period of AIDS. Nature (London) 362:359-362.
116. Emilie, D., R. Fior, B. Jarrousse, K. A. Marfaing, D. Merrien, D. Vevergne, M. C. Crevon, M. C. Malliot, and P. Galanaud. 1994. Cytokines in HIV infection. Int. J. Immunopharmacol. 16:391-396.
117. Ennen, J., I. Seipp, S. G. Norley, and R. Kurth. 1990. Decreased accessory cell function of macrophages after infection with HIV-1 in vitro. Eur. J. Immunol. 20:2451-2456.
118. Epstein, L. G., and H. G. Gendelman. 1993. HIV-1 infection of the nervous system: pathogenic mechanisms. Ann. Neurol. 33:429-436.
119. Estaquier, J., T. Idziorek, F. deBels, F. Barre-Sinoussi, B. Hurtrel, A. M. Aubertin, A. Venet, M. Mehtali, E. Muchmore, P. Michel, Y. Mouton, M. Girard, and J. C. Ameisen. 1994. Programmed cell death and AIDS: significance of T cell apoptosis in pathogenic and nonpathogenic primate lentiviral infections. Proc. Natl. Acad. Sci. USA 91:9431-9435.
120. Fahey, J. L., H. Prince, M. Weaver, J. Groopman, B. Visscher, T. Schwartz, and R. Detels. 1984. Quantitative changes in T helper or T suppressor/ cytotoxic lymphocyte subsets that distinguish AIDS from other immune subset disorders. Am. J. Med. 76:95-100.
121. Fan, J., H. Z. Bass, and J. L. Fahey. 1993. Elevated IFNgamma and decreased IL-2 gene expression are associated with HIV infection. J. Immunol. 151:5031-5040.
122. Fauci, A. S. 1988. The human immunodeficiency virus: infectivity and mechanisms of pathogenesis. Science 239:617-622.
123. Fennie, C., and L. Lasky. 1989. Model for intracellular folding of human immunodeficiency virus type 1 gp120. J. Virol. 63:639-646.
124. Field, E. H., T. M. Rouse, A. L. Flemming, I. Jamali, and J. S. Cowdrey. 1992. Altered IFN-γ and IL-4 secretion in mice partially depleted of CD4 T cells by anti-CD4 monoclonal antibody. J. Immunol. 149:1131-1137
125. Fields, A. P., D. P. Bednarik, A. Hess, and W. S. May. 1988. Human immunodeficiency virus induces phosphorylation of its cell surface receptor. Nature (London) 333:278-280.
126. Finkel, T. H., and N. K. Banda. 1994. Indirect mechanisms of HIV patho. genesis: how does HIV kill T cells? Curr. Opin. Immunol. 6:605-615.
127. Finkel, T. H., G. T. Williams, N. K. Banda, M. F. Cotton, T. Curiel, C. Monks, T. W. Baba, R. M. Ruprecht, and A. Kupfer. 1995. Apoptosis occurs predominantly in bystander cells and not in productively infected cells on HIV- and SIV-infected lymphocytes. Nat. Med. 1:129-134.
128. Fleury, S., D. Lammare, S. Meloche, S. E. Ryu, C. Cantin, W. Hendrikson, and R. P. Sekaly. 1991. Mutational analysis of the interaction between CD4 and MHC class II: class II antigens contact CD4 on a surface opposite the gp120-binding site. Cell 66:1037-1049.
129. Folks, T. M. 1991. Human immunodeficiency virus in bone marrow: still more questions than answers. Blood 77:1625.
130. Folks, T. M., S. W. Kessler, J. M. Orenstein, J. S. Justement, E. S. Jaffe, and A. S. Fauci. 1988. Infection and replication of HIV-1 in purified progenitor cells of the normal human bone marrow. Science 242:919-922.
131. Forte, P., A. Aiuti, L. Pozzi, F. Citrella, A. Fattorossi, G. B. Rossi, and A. Fantoni. 1993. Human CD4 produced in lymphoid cells of transgenic mice binds HIV gp120 and modifies the subsets of mouse T cell populations. Immunogenetics 38:455-459.
132. Foster, S., P. Beverley, and R. Aspinall. 1995. gp120-induced programmed cell death in recently activated T cells without subsequent ligation of T cell receptor. Eur. J. Immunol. 25:1778-1782.
133. Francis, M. L., and M. S. Meltzer. 1993. Induction of IFN-alpha by HIV-1 monocyte enriched PBMC requires gp120-CD4 interaction but not virus replication. J. Immunol. 151:2208-2216.
134. Freed, E. O., and M. A. Martin. 1995. The role of HIV-1 envelope glycoproteins in virus infection. J. Biol. Chem. 270:23883.
135. Fust, G., M. P. Dierich, and T. Hidvegi. 1995. Role of humoral factors in progression of HIV disease. Immunol. Today 16:167-169.
136. Gartner, S., P. Markovitz, D. M. Markovitz, M. H. Kaplan, R. C. Gallo, and M. Popovic. 1986. The role of mononuclear phagocytes in HTLV-III/LAV infection. Science 233:215-219.
137. Garziosi, C., G. Pantaleo, J.-P. Fortin, J. F. Demarest, O. J. Cohen, R.-P. Sekaly, and A. S. Fauci. 1994. Lack of evidence for the dichotomy of Th1 and Th2 predominance in HIV-infected individuals. Science 265:248-252.
138. Gaulton, G., L. F. Brass, D. Kozbor, C. H. Plecher, and J. A. Hoxie. 1992. Inhibition of T cell antigen receptor dependent phosphorylation of CD4 HIV-1 infected cells. J. Biol. Chem. 267:4102-4109.
139. Gendelman, H. E., R. M. Friedman, S. Joe, L. M. Baca, J. A. Turpin. G. Dveksler, M. S. Meltzer, and C. Dieffenback. 1991. A selective defect of Interferon alpha production in HIV-infected monocytes. J. Exp. Med. 172:1433-1442.
140. Gessani, S., P. Puddu, B. Varano, P. Borghi, L. Conti, L. Fantuzzi, and F. Belardelli. 1994. Induction of beta Interferon by human immunodeficiency virus type 1 and its gp120 protein in human monocytes-macrophages: role of beta interferon in restriction of virus replication. J. Virol. 68:1983-1986.
141. + T cells of humoral and cellular immunity in sheep. Immunology 77:38-42.
142. Glaichenhaus, N., N. Shastri, D. R. Littman, and J. M. Turner. 1991. Requirement for association of p56lck with CD4 in antigen-specific signal transduction in T cells. Cell 64:511-520.
143. Golding, H., A. Robey, F. T. Gates, W. Linder, P. R. Beining, T. Hoffman, and B. Golding. 1988. Identification of homologous regions in HIV gp41 and human MHC class II domains. J. Exp. Med. 167:914-923.
144. Golding, H., G. M. Shearer, K. Hillman, P. Lucas, J. Manischewitz, R. A. Zajac, M. Clerici, R. E. Gress, R. N. Boswell, and B. Golding. 1989. Common epitope in HIV-gp41 and HLA class II elicits immunosuppressive autoantibodies capable of contributing to immune dysfunction in HIV-1 infected individuals. J. Clin. Invest. 83:1430-1435.
145. Goldman, F., W. A. Jensen, G. L. Johnson, L. Heasley, and J. C. Cambier. 1994. gp120 ligation of CD4 induces p56lck activation and TCR desensitization independent of TCR tyrosine phosphorylation. J. Immunol. 153:2905-2917.
146. Goudsmit, J., N. K. Back, and P. L. Nara. 1991. Genomic diversity and antigenic variation of HIV-1: links between pathogenesis, epidemiology and vaccine development. FASEB J. 5:2427-2436.
147. Gougeon, M. L., G. Dadagilo, S. Garcia, H. M. Alouf, R. Roue, and L. Montagnier. 1993. Is a dominant superantigen involved in AIDS pathogenesis? Lancet 342:50-51.
148. Gougeon, M.-L., S. Garcia, J. Heneey, R. Tschopp, H. Lecoeur, D. Guetard, V. Rame, C. Dauglet, and L. Montagnier. 1993. Programmed cell death in AIDS related HIV and SIV infections. AIDS Res. Hum. Retroviruses 9:553-563.
149. Griscelli, C., and B. Grospeirre. 1989. Combined immunodeficiency with defective expression in MHC class II genes. Immunodefic. Rev. 1:135-153.
150. Groenink, M., R. A. M. Fouchier, S. Broersen, C. H. Baker, M. Koot, A. B. V. Wout, H. G. Huisman, F. Miedema, M. Tersmette, and H. Scuitemaker. 1993. Relation of phenotype evolution of HIV-1 to envelope V2 cofiguration. Science 260:1513-1515.
151. + T cells from human immunodeficiency virus-infected asymptomatic individuals. J. Exp. Med. 175:331-340.
152. + T cells in major histocompatibility complex class II-deficient mice. Science 253:1417-1420.
153. Guilian, D., E. Wendt, K. Vaca, and C. A. Noonan. 1993. Envelope glycoprotein of human immunodeficiency virus type 1 induces release of neurotoxins from monocytes. Proc. Natl. Acad. Sci. USA 90:2769-2773.
154. Guo. H., F. Veronese, E. Tschachler, R. Pal, V. S. Kalyanaraman, R. C. Gallo, and M. Reitz. 1990. Characterization of an HIV-1 point mutation blocked in envelope glycoprotein cleavage. Virology 174:217-224.
155. Gupta, S. 1993. Signal transduction defect in the acquired immunodeficiency syndrome and AIDS related complex. Thymus 22:83-90.
156. Gupta, S., S. Aggarwal, C. Kim, and S. Gollapudi. 1994. Human immunodeficiency virus-1 gp120 induces changes in protein kinase C isozymes - a preliminary report. Int. J. Immunopharmacol. 16:197-204.
157. Gupta, S., and B. Vayuvegula. 1987. Human immunodeficiency virus-associated changes in signal transduction. J. Clin. Immunol. 7:486-489.
158. + lymphocyte function with early human immunodeficiency virus. Proc. Natl. Acad. Sci. USA 86:1993-1997.
159. Gurram, M., N. Chirmule, X.-P. Wang, N. Ponugoti, and S. Pahwa. 1994. Increased spontaneous secretion of interleukin 6 and tumor necrosis factor alpha by peripheral blood lymphocytes of HIV infected children. Pediatr. Infect. Dis. J. 13:496-501.
160. Habeshaw, J. A., A. G. Dalgleish, L. Bountiff, A. L. Newell, D. Wilks, L. C. Walker, and F. Manca. 1990. AIDS pathogenesis: HIV envelope protein and its interaction with cell proteins. Immunol. Today 11:418-425.
161. Harrel, R. A., G. J. Ciacialo, T. D. Copeland, S. Oroszlan, and R. Snyderman. 1989. Suppression of the respiratory burst of human monocytes by a synthetic peptide homologous to envelope proteins of human and animal tetroviruses. J. Immunol. 136:3517-3520.
162. Haurum, J. S., S. Thiel, L. M. Jones, P. B. Fisher, S. B. Laursen, and J. C. Jensenius. 1993. Complement activation upon binding of mannan binding protein to HIV envelope glycoproteins. AIDS 7:1307-1313.
163. Haynes, B. 1993. Scientific and social issues for HIV vaccine developments. Science 260:1279-1286.
164. Hays, E. F., C. H. Uttenbogaart, J. C. Brewer, L. W. Vollger, and J. A. Zack. 1992. In vitro studies of HIV-1 expression in thymocytes from infants and children. AIDS 6:265-272.
165. Heyes, M. P., K. Saito, and S. P. Markey. 1992. Human macrophages convert L-tryptophan into neurotoxin quinolinic acid. Biochem. J. 283:633-635.
166. Hivroz, C., F. Mazerolles, M. Soula, R. Fagard, S. Graton, S. Meloche, R.-P. Sekaly, and A. Fischer. 1993. Human immunodeficiency virus gp120 and derived peptides activate protein tyrosine kinase p56 lck in human CD4 T lymphocytes. Eur. J. Immunol. 23:600-607.
167. Ho, D. D., A. U. Neumann, A. S. Perlson, W. Chen, J. M. Leonard, and M. Markovitz. 1995. Rapid turnover of plasma virions and CD4 lymphocytes in HIV-1 infection. Nature (London) 373:123-126.
168. + T cells. AIDS 7:633-638.
169. Hofmann, B., P. Nishanian, T. Nguyen, P. Insixiengmay, and J. L. Fahey. 1993. Human immunodeficiency virus proteins induce the inhibitory cAMP/ protein kinase A pathway in normal lymphocytes. Proc. Natl. Acad. Sci. USA 90:6676-6680.
170. Hofmann. B., P. Nishanian, T. Nguyen, M. Liu, and J. L. Fahey. 1993. Restoration of T cell function in HIV infected patients by reduction of tatracellular cAMP levels with adenosine analogues. AIDS 7:659-664.
171. Hornellf, G., A. H. Guse, H. Schulze-Koops, J. R. Kalden, G. R. Burmester, and F. Emmrich. 1993. Human CD4 modulation in vivo induced by antibody treatment. Clin. Immunol. Immunopathol. 66:80-90.
172. Houlgatte, R., P. Scarmato, S. E. Marhomy, M. Martin, M. Ostankovitch, S. Lafosse, A. Vervisch, C. Auffray, and D. P. Tonneau. 1994. MHC class II antigens and the HIV envelope glycoprotein gp120 bind to the same face of CD4. J. Immunol. 152:4475-4488.
173. Hourse, J. M., S. Bhat, S. L. Spitalnik, M. Laughlin, K. Stefano, D. H. Silderberg, and F. Gonzalvez-Scrano. 1991. Inhibition of entry of HIV-1 in neural cell lines by antibodies against galactosyl ceramide. Science 253:320-323.
174. Hu, R., N. Oyaizu, V. S. Kalyanaraman, and S. Pahwa. 1994. HIV-1 gp160 as a modifier of Th1 and Th2 cytokine responses: gp160 suppresses IFN-γ and IL-2 production concomittantly with enhanced IL-4 production in vitro. Clin. Immunol. Immunopathol. 73:245-251.
175. Hu, R., et al. Unpublished data.
176. Hwang, S. R., T. J. Boyle, K. Lyerly, and B. R. Cullen. 1991. Identification of the envelope V3 loop as the primary determinant of cell tropism in HIV-1. Science 253:71-74.
177. Imberti, L., A. Sottini, A. Bettinardi, M. Pouti, and D. Primi. 1991. Selective depletion in HIV infection of T cells that bear specific T cell receptor V b sequences. Science 254:860-862.
178. Iskandar, Y. L., V. Georgoulias, D. Vittecoq, M. Nugeyre, A. Ammar, C. Clemenceau, F. B. Sinoussi, J.-C. Chermann, L. Schwartzenberg, and C. Jasmin. 1987. Peripheral blood adherent cells from AIDS patients inhibit normal T colony growth through decreased expression of IL-2R and production of IL-2. Leuk. Res. 11:753-760.
179. + T cells inhibits the binding activity of NFAT, NF-κB, and AP-1, three nuclear factors regulating interleukin 2 gene enhancer activity. Eur. J. Immunol. 24:2646-2652.
180. Jameison, B., P. Rao, L. Kong, B. Hahn, G. Shaw, L. Hood, and S. Kent. 1988. Location and chemical synthesis of a binding site for HIV-1 on the CD4 protein. Science 240:1335-1339.
181. Janeway, C. 1991. Mls makes little sense. Nature (London) 349:459-461.
182. Janeway, C. A. 1991. The co-receptor function of CD4. Semin. Immunol. 3:153-160.
183. Janeway, C. A. 1994. Thymic selection: two pathways to life and two to death. Immunity 1:306-308.
184. Jo, C., and J. Miller. 1992. Differential induction of transcription factors that regulate the interleukin 2 gene during anergy induction and restimulation. J. Exp. Med. 175:1327-1336.
185. + cells in chimpanzees. Clin. Exp. Immunol. 93:301-307.
186. Juszczak, R. J., J. Turchin, A. Truneh, J. Culp, and S. Kassis. 1991. Effect of human immunodeficiency virus gp120 glycoprotein on the association of the protein tyrosine kinase p56lck with the CD4 on human T lymphocytes. J. Biol. Chem. 266:11176-11183.
187. Kalamas, S. A., R. P. Johnson, A. K. Trocha, M. J. Dyan, H. S. Ngo, R. T. D'Aquilla, J. T. Kurnick, and B. D. Walker. 1994. Longitudinal analysis of T cell receptor gene usage by HIV-1 envelope specific cytotoxic T lymphocyte clones reveals a limited TCR repertoire. J. Exp. Med. 179:1261-1271.
188. Kalyanaraman, V. S., D. M. Rausch, J. Osnorne, M. Padgett, K. M. Hwang, J. D. Lifson, and L. E. Eiden. 1990. Evidence by peptide mapping the region CD4 (81-92) is involved in the gp120/CD4 interaction leading to HIV infection and HIV-induced syncytia. J. Immunol. 145:4072-4078.
189. Kaneshima, H., L. Su, M. L. Bonyhadi, R. I. Connor, D. D. Ho, and J. M. McCune. 1994. Rapid-high, syncytium-inducing isolates of human immunodeficiency virus type 1 induce cytopathicity in human thymus of the SCID-hu mouse. J. Virol. 68:8188-8192.
190. Kang, S.-M., B. Beverly, A. C. Tran, K. Brorson, R. Schwartz, and M. Leonardo. 1992. Transactivation by AP-1 is a molecular target of T cell clonal anergy. Science 257:1134-1138.
191. Kanner, S. B., and O. K. Haffar. 1995. HIV-1 down regulates Cd4 costimulation of TCR/CD3 directed tyrosine phosphorylation through Cd4/lck dissociation. J. Immunol. 154:2996-3005.
192. Karin, M. 1992. Signal transduction from the cell surface in development and disease. FASEB J. 6:2581-2590.
193. Katsikis, P. D., E. S. Wunderlich, C. A. Smith, L. A. Herzenberg, and L. A. Herzenberg. 1995. Fas antigen stimulation induces marked apoptosis of T lymphocytes in HIV infected individuals. J. Exp. Med. 181:2029-2036.
194. Kaufmann, R., D. Laroche, K. Buchner, F. Hucho, C. Rudd, C. Lindschau, P. Ludwig, A. Hoer, E. Oberdisse, J. Kopp, I. J. Korner, and H. Repke. 1992. The HIV-1 surface protein gp120 has no effect on transmembrane signal transduction. J. Acquired Immune Defic. Syndr. 15:760-770.
195. Kekow, J., W. Wachman, J. A. McMutchan, M. Cronin, D. A. Carson, and M. Lotzz. 1990. TGF-beta and non-cytopathic mechanisms of immunodeficiency in HIV infection. Proc. Natl. Acad. Sci. USA 87:8321-8325.
196. + lymphocyte immunologically reactive with antibody inhibiting syncytia induced by HIV-1. J. Biol. Chem. 265:21979-21985.
197. King, L. B., and J. D. Ashwell. 1993. Signalling for death in lymphoid cells. Curr. Opin. Immunol. 5:368-373.
198. Kion, T. A., and G. W. Hoffmann. 1991. Anti-HIV and anti-MHC antibodies in alloimmune and autoimmune mice. Science 253:1138-1140.
199. Klatzman, D., E. Champagne, S. Chamaret, J. Gruest, D. Guetard, T. Hercend, J. C. Gluckman, and L. Montagnier. 1984. T lymphocyte T4 molecule behaves as the receptor for human retrovirus LAV. Nature (London) 312:767-768.
200. Koenig, S., H. E. Gendelman, T. Orenstein, M. C. dalCanto, G. Pezechkpour, M. Yungbluth, F. Janotta, A. Akasmit, M. Martin, and A. S. Fauci. 1986. Detection of AIDS virus in macrophages of brain tissue from AIDS patients with encephalopathy. Science 233:1089-1093.
201. Koff, W. C. 1994. The next steps toward a global AIDS vaccine. Science 266:1335-1337.
202. Koff, W. C., and D. F. Hoth. 1988. Development and testing of AIDS vaccines. Science 241:426-432.
203. Koka, P., K. He, J. A. Zack, S. Kitchen, W. Peacock, I. Fried, T. Tran, S. Yashar, and J. E. Merril. 1995. HIV-1 envelope proteins induce IL-1, TNFa and nitric oxide in glial cultures derived from fetal, neonatal, and adult human brain. J. Exp. Med. 182:941-952.
204. Kollman, T. R., A. Kim, M. Mantovani, M. Hachamovitch, A. Rubenstein, M. M. Goldstein, and H. Goldstein. 1995. Divergent effects of chronic HIV-1 infection on human thymocyte maturation in SCID-hu mice. J. Immunol. 154:907-921.
205. Kornfeld, H., W. W. Cruickshank, S. Pyle, J. S. Berman, and D. M. Center. 1988. Lymphocyte activation by HIV-1 envelope glycoprotein. Nature (London) 335:445-454.
206. Krowka, J., D. Stiles, J. Mills, H. Hollander, L. McHugh, M. Busch, L. Wilhelm, and L. Blackwood. 1988. Effects of interleukin 2 and large envelope glycoprotein (gp120) of HIV on lymphocyte proliferative responses to cytomegalovirus. Clin. Exp. Immunol. 72:179-185.
207. Lacroix, F., D. Y. Zhao, C. A. Izaguirre, and L. G. Filion. 1993. Suppression by HIV of IL-1 and IL-6 secretion in accessory cells: AC function defect partially corrected with exogenous IL-1 and IL-6. Clin. Immunol. Immunopathol. 67:109-116.
208. Landau, N. R., M. Warton, and D. R. Littman. 1988. The envelope glycoprotein of the human immunodeficiency virus binds to the immunoglobulin-like domain of CD4. Nature (London) 334:159-162.
209. Landmann, I. D., E. Kaltenhauser, H.-D. Flad, and M. Ernst. 1994. HIV-1 envelope proteins gp120 affect phenotype and function of monocytes in vitro. J. Leukocyte Biol. 55:545-551.
210. Lane, H. C., L. C. Edgar, G. Wahlen, A. H. Rook, and A. S. Fauci. 1983. Abnormalities of B cell activation and immunoregulation in patients with acquired immunodeficiency syndrome. N. Engl. J. Med. 309:453-458.
211. Lane, H. C., H. Masur, E. P. Gelmann, D. L. Longo, R. G. Steis, T. Chused, G. Whalen, L. C. Edgard, and A. S. Fauci. 1985. Correlation between immunological function and clinical subpopulations of patients with AIDS. Am. J. Med. 78:417-422.
212. Lasky, A., G. Nakamura, D. H. Smith, C. Fennie, E. Shimasaki, E. Patzer, P. Berman, T. Gregory, and D. J. Capon. 1987. Delineation of a region of the human immunodeficiency virus type 1 gp120 glycoprotein critical for interaction with CD4 receptor. Cell 50:975-985.
213. Lathey, J. L., J. M. Agosti, J. A. Nelson, L. Corey, S. A. Gregory, J. H. Morrison, T. S. Edgingtin, and M. B. Oldstone. 1990. A selective defect in tissue factor mRNA expression in monocytes from AIDS patients. Clin. Immunol. Immunopathol. 54:1-13.
214. Laurence, J., S. Hodtsev, and D. Posnett. 1992. Superantigen implicated in dependence of HIV-1 replication in T cells on TCR Vb expression. Nature (London) 358:255-259.
215. Laurent-Crawford, A. G., B. Krust, Y. Rivierem, C. Desgranges, S. Muller, M. P. Kiney, C. Dauget, and A. G. Hovanessian. 1993. Membrane expression of HIV envelope glycoprotein triggers apoptosis in CD4 T cells. AIDS Res. Hum. Retroviruses 9:761-773.
216. Leahy, D. J. 1995. A structural view of CD4 and CD8. FASEB J. 9:17-25.
217. Lederman, S., M. J. Yellin, A. Krishevsky, S. Belko, J. J. Lee, and L. Chess. 1992. Identification of a novel cell surface protein on activated CD4+ T cells that induce contact dependent B cell differentiation (help). J. Exp. Med. 175:1091-1101.
218. Lee, M. R., D. D. Ho, and M. E. Gurney. 1987. Functional interaction and partial homology between HIV and neuroleukin. Science 237:1047-1051.
219. Lee, S. C., D. W. Dickson, W. Liu, C. Bronsan. 1993. Induction of NO synthetase activity in human astrocytes by IL-1 and IFN-γ. J. Neuroimmunol. 46:19-24.
220. Leiderman, I. Z., M. L. Greenberg, B. R. Adelsberg, and F. P. Seigal. 1987. A glycoprotein inhibitor of in vitro granulopoiesis associated with AIDS. Blood 70:1267-1272.
221. + T lymphocytes. J. Acquired Immune Defic. Syndr. 7:340-348.
222. Letvin, N. L. 1993. Vaccines against HIV-progress and prospects. N. Engl. J. Med. 329:1400-1405.
223. Levilzke, A., and A. Gazit. 1996. Tyrosine kinase inhibition: an approach to drug development. Science 267:1882-1886.
224. Levy, J. A. 1993. Pathogenesis of human immunodeficiency virus infection. Microbiol. Rev. 57:183-289.
225. + T cells from HIV-infected persons. J. Immunol. 153:412-420.
226. Lifson, J., K. Hwang, P. Naran, B. Fraser, M. Padgett, N. Dunlop, and L. Eiden. 1988. Synthetic CD4 peptide derivatives that inhibit HIV infection and cytopathicity. Science 241:712-716.
227. Linette, G. P., R. J. Hartzman, J. A. Ledbetter, and C. H. June. 1988. HIV-1 infected T cells show a selective signalling detect after perturbation of CD3 antigen receptor. Science 241:573-576.
228. Lipton. S. A. 1992. Memantine prevents HIV coat protein induced neuronal injury in vitro. Neurology 42:1403-1405.
229. Littman, D. R. 1987. The structure of CD4 and CD8 genes. Annu. Rev. Immunol. 5:561-584.
230. Lombardi, V., P. Rossi, L. Romiti, M. Mattei, F. Mariani, F. Poccia, and V. Colizzi. 1992. HIV gp120 epitope immunodominance in MRL/lpr mice. AIDS Res. Hum. Retroviruses 8:1081-1082.
231. Lopalco, L., C. deSantis, R. Meneveri, R. Longhi, E. Ginelli, F. Grassi, A. G. Siccardi, and A. Beretta. 1993. HIV-1 gp120 C5 region mimics the HLA class II alpha 1 binding domain. Eur. J. Immunol. 23:2016-2021.
232. Louache, F., N. Debeli, A. Marandin, L. Coulombei, and W. Vainchenker. 1994. Expression of CD4 by human hematopoietic progenitors. Blood 84:3344-3355.
233. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jack. 1993. p53 is required for radiation induced apoptosis in mouse thymocytes. Nature (London) 362:847-849.
234. + cells expressing gp160 of human immunodeficiency virus type 1. J. Virol. 68:390-399.
235. Lund, U., J. Hansen, A. M. Sorensen, E. Mosekilde, J. D. Nielsen, and J. E. Hansen. 1995. Increased adhesion as a mechanism of antibody-dependent and antibody-independent complement-mediated enhancement of humas immunodeficiency virus infection. J. Virol. 69:2393-2400.
236. Macchia, D., F. Almerigogna, P. Parronchi, A. Ravina, E. Maggi, and S. Romagniani. 1993. Membrane tumor necrosis factor alpha is involved in the polyclonal B cell activation induced in HIV infected human T cells. Nature (London) 363:464-466.
237. + T cell clones to induce noncognate contact-dependent polyclonal β-cell activation. J. Immunol. 146:3413-3417.
238. Maciejewski, J. P., F. F. Weichold, and N. S. Young. 1994. HIV-1 suppression of hematopoiesis in vitro mediated by envelope glycoproteins and TNF-alpha. J. Immunol. 153:4303-4310.
239. Macilwain, C. 1994. US puts large-scale AIDS vaccine trials on ice as 'premature'. Nature (London) 369:59.
240. Maddon, P. J., A. G. Dalgleish, J. S. McDougal, P. R. Clapham, R. A. Weiss, and R. Axel. 1986. The T4 gene encodes the AIDS virus receptor and is expressed in the immune system and the brain. Cell 47:333-348.
241. Maddon, P. J., D. R. Littman, M. Godfrey, D. E. Maddon, L. Chess, and R. Axel. 1985. The isolation and nucleotide sequence of a cDNA encoding the T cell surface protein T4: a new member of the immunoglohulin gene family. Cell 42:93-104.
242. Maddon, P. J., S. M. Molineaux, D. E. Maddon, K. A. Zimmerman, M. Godfrey, F. W. Alt, L. Chess, and R. Axel. 1987. Structure and expression of the human and mouse T4 genes. Proc. Natl. Acad. Sci. USA 84:9155-9159.
243. Maggi, E., M. Mazzetti, A. Ravina, R. Manetti, M. Del Carli, F. Annunziato, M. P. Piccini, M. Carbonari, A. M. Pesce, G. Del Prete, and S. Romangniani. 1994. HIV can favor a Th1/Th0 shift and preferentially replicates in Th2 and Th0 cells. Science 265:244-248.
244. Manca, F., J. A. Habeshaw, and A. G. Dalgleish. 1990. HIV envelope glycoprotein. antigen-specific T cell responses, and soluble CD4. Lancet 335:811-815.
245. Mann, D. L., F. Lasane, M. Popovic, L. A. Arthur, W. G. Robey, W. A. Blattner, and M. J. Newman. 1987. HTLV III large envelope protein (gp120) suppresses PHA-induced lymphocyte blastogenesis. J. Immunol. 138:2640-2644.
246. Mano, H., and J.-C. Cherman. 1991. Fetal HIV-1 infection in different organs in the second trimester. AIDS Res. Hum. Retroviruses 7:83-88.
247. March, M., and A. Dalgleish. 1987. How do human immunodeficiency viruses enter cells? Immunol. Today 8:369-371.
248. Marschung, P., J. Sodroski, R. Wurzner, and M. P. Dierich. 1995. Decay accelerating factor (CD55) protects HIV-1 from inactivation by complement. Eur. J. Immunol. 25:285-290.
249. Martin, S. J., and D. R. Green. 1995. Protease activation during apoptosis: death by a thousand cuts? Cell 82:349-352.
250. + T cell in vitro. Differential induction of apoptosis in these cells. J. Immunol. 152:330-342.
251. Marx, J. 1991. Clue found to T cell loss in AIDS. Nature (London) 254:798-800.
252. Mascola, J. R., B. J. Mathieson, P. M. Zack, M. C. Walker, S. B. Halstead and D. S. Burke. 1993. Summary report: workshop of the potential risk of antibody-dependent enhancement in human HIV vaccine trials. AIDS Res. Hum. Retroviruses 9:1175-1184.
253. Mathews, T. J. 1994. Dilemma of neutralization resistance of HIV-1 field isolates and vaccine development. AIDS Res. Hum. Retroviruses 10:631-632.
254. Mathews, T. J., K. J. Weinhold, H. K. Lyerly, A. J. Langlois, H. Wigzell, and D. P. Bolognesi. 1987. Interaction between the human T-cell lymphotropic virus type IIIB envelope glycoprotein gp120 and the surface antigen CD4: role of carbohydrate in binding and cell fusion. Proc. Natl. Acad. Sci. USA 84:5424-5428.
255. Maury, W., B. J. Potts, and A. B. Rabson. 1989. HIV-1 infection of first trimester and term human placental tissue: a possible mode of maternal-fetal transmission. J. Infect. Dis. 160:583-588.
256. McCloskey, T. W., N. Oyaizu, M. Kaplan, and S. Pahwa. 1995. Expression of the fas antigen in patients with HIV-1. Cytometry 22:111-114.
257. McCune, J. M., L. B. Rabin, M. B. Feinberg, M. Lieberman, J. C. Kosek, G. R. Reyes, and I. L. Weissman. 1988. Endoproteolytic cleavage of gp160 is required for the activation of HIV. Cell 53:55-67.
258. McCune, M. 1991. HIV-1. The infective process. Cell 64:351-363.
259. McFadden, D. C., M. A. Powles, J. G. Smith, A. M. Flattery, K. Bartizal, and D. M. Schmatz. 1994. Use of anti-CD4 hybridoma cells to induce Pneumocystis carinii in mice. Infect. Immun. 62:4887-4892.
260. Meltzer, M. S., D. R. Skillman, D. L. Hoover, B. D. Hanson, J. A. Turpin, D. C. Kalter, and H. E. Gendelman. 1990. Macrophages and the human immunodeficiency virus. Immunol. Today 11:217-223.
261. Merril, J., Y. Koyanagi, and I. S. Y. Chen. 1989. Interleukin 1 and tumor necrosis factor alpha can be induced from mononuclear phagocytes by human immunodeficiency virus type 1 binding to the CD4 receptor. J. Virol. 63:4404-4408.
262. Merril, J. E., and I. S. Y. Chen. 1991. HIV-1, glial cells and cytokines in AIDS nervous system disease. FASEB J. 5:2391-2397.
263. Mestecky, J., and S. Jackson. 1994. Reassessment of the impact of mucosal immunity in infection with HIV and design of relevant vaccines. J. Clin. Immunol. 14:259-272.
264. Meyaard, L., H. Kiuper, S. A. Otto, K. C. Wolthers, R. A. W. Lier, and F. Miedema. 1995. Evidence for intact costimulation via CD28 and CD27 molecules in hyporesponsive T cells from HIV-infected individuals. Eur. J. Immunol. 25:232-237.
265. Meyaard, L., S. A. Otto, R. R. Jonker, M. J. Mijnster, R. P. M. Keet, and F. Miedema. 1992. Programmed death of T cell in HIV-1 infection. Science 257:217-219.
266. Meyaard, L., S. A. Otto, I. P. M. Keel, M. T. L. Marijke, T. L. Roos, and F. Miedema. 1994. Programmed death of T cells in human immunodeficiency virus infection: no correlation with progression to disease. J. Clin. Invest. 93:982-988.
267. Meyaard, L. H. Schuitmaker, and F. Miedema. 1993. T cell dysfunction in HIV infection: anergy due to defective antigen presentation cell function? Immunol. Today 14:161-164.
268. Meyerhans, A., R. Cheyníer, J. Albert, M. Seth, S. Kwok, K. Skinsky, L. M. Manson, B. Asjo, and S. Wain-Hobson. 1989. Temporal fluctuations in HIV quasispecics in vivo are not reflected by sequential HIV isolations. Cell 58:901-910.
269. Miedema, F., A. J. Chantal-Petit, F. G. Terpstra, J. K. M. E. Schattenkerk, F. de Wolf, B. J. M. Al, M. Roos, J. M. A. Lange, S. A. Danner, J. Goudsmit, and T. A. Schellekens. 1988. Immunological abnormalities in human immunodeficiency virus infected asymptomatic homosexual men. J. Clin. Invest. 82:1908-1914.
270. Mittler, R. S., and M. K. Hoffman. 1990. Synergism between HIV gp120 and gp120-specific antibody in blocking human T cell activation. Science 245:1380-1382.
271. Mizochi, T., T. Mathews, M. Kato, J. Hamako, K. Tatani, J. Solomon, and T. Feizi. 1990. Diversity of oligosaccharide structures on the envelope glycoprotein gp120 of human immunodeficiency virus 1 from the lympho-blastoid cell line H9. J. Biol. Chem. 265:8519-8524.
272. Mizukami, T., T. Fuerst, E. Berger, and B. Moss. 1988. Binding region for HIV and epitopes for HIV blocking mAb of the CD4 molecules defined by site-directed mutagenesis. Proc. Natl. Acad. Sci. USA 85:9273-9277.
273. Molina, J.-M., D. T. Scadden, R. Byrn, C. A. Dinarello, and J. E. Groopeman. 1989. Production of TNF-alpha and interleukin 1b by monocytic cells infected with HIV. J. Clin. Invest. 84:733-737.
274. Molina, J. M., D. T. Scadden, M. Sakaguchi, B. Fuller, A. Woon, and J. E. Groopeman. 1990. Lack of evidence for infection or effect on growth of hematopoietic cells after in vivo or in vitro exposure to HIV. Blood 76:2476.
275. Mollace, V., M. Colasanti, T. Persichini, G. Bagetta, G. M. Lauro, and G. Nistico. 1993. HIV gp120 glycoprotein stimulates the inducible isoform of NO synthetase in human cultured astrocytoma cells. Biochem. Biophys. Res. Commun. 194:439-445.
276. Monroe, J. G., and L. E. Silberstein. 1995. HIV-mediated B lymphocyte activation and lymphagenesis. J. Clin. Immunol. 15:61-68.
277. Moore, K. W., and T. Mossman. 1991. The role of interleukin 10 in cross-regulation of Th1 and Th2 responses. Immunol. Today 12:49-52.
278. Mosier, D., and H. Sieburg. 1994. Macrophage-tropic HIV: critical for AIDS pathogenesis? Immunol. Today 15:332-339.
279. Mossman, T. R., and R. L. Coffman. 1989. Th1 and Th2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu. Rev. Immunol. 7:145-173.
280. Mountz, J. D., T. Zhou, J. Wu, W. Wang, X. Su, and J. Cheng. 1995. Regulation of apoptosis in immune cells. J. Clin. Immunol. 15:1-16.
281. Muller, F., H. Rollag, and S. S. Friand. 1990. Reduced oxidative burst responses in monocytes and monocyte-derived macrophages from HIV-infected subjects. Clin. Exp. Immunol. 82:10-15.
282. Muller, W. E. G., H. C. Schroder, H. Uchiyama, J. Drapper, and J. Bormann. 1992. gp120 of HIV-1 induces apoptosis in rat cortical cell cultures: prevention by menantine. Eur. J. Pharmacol. 226:209-214.
283. Muro-Cacho, C., G. Pantaleo, and A. S. Fauci. 1995. Analysis of apoptosis in lymph nodes of HIV infected persons. J. Immunol. 154:5555-5566.
284. Nabavi, N., G. J. Freeman, A. Gault, D. Godfrey, L. Nadler, and L. H. Glimeher. 1992. Signalling through the MHC class II cytoplasmic domain is required for antigen presentation and induces B7 expression. Nature (London) 360:266-268.
285. Nair, M. P. N., R. Pottahil, E. P. Heimer, and S. A. Schwartz. 1988. Immunoregulatory activities of human immunodeficiency virus (HIV) proteins: effect of HIV recombinant and synthetic peptides on immunoglobulin synthesis and proliferative responses by normal lymphocytes. Proc. Natl. Acad. Sci. USA 85:6498-6502.
286. Nakajima, K., O. Martinez-Maza, T. Hirano, E. Breen, P. G. Nishanian, J. F. Salazar-Gonzalez, J. F. Fahey, and T. Kishimoto. 1989. Induction of IL-6 (B cell stimulatory factor-2/IFN-beta 2) production by HIV. J. Immunol. 142:531-536.
287. Nara, P. L., R. R. Garrity, and J. Goudsmit. 1991. Neutralization of HIV-1: a paradox of humoral proportions. FASEB J. 5:2437-2455.
288. Nathan, C. 1992. Nitric oxide as a secretory product of mammalian cells. FASEB J. 6:3051-3064.
289. Nisini, R., A. Aiuti, P. M. Matricardi, A. Fattorossi, C. Ferlini, R. Biseli, I. Mezzaroma, E. Pinter, and R. D'Amelio. 1994. Lack of evidence for a superantigen in lymphocytes from HIV-discordant monozygotic twins. AIDS 8:443-449.
290. Nottet, H. S., L. deGraaf, M. deVos, L. J. Baker, J. A. van Strijp, M. R. Visser, and J. Verhoef. 1993. Phagocytic function of monocyte-derived macrophages is not affected by HIV-1 infection. J. Infect. Dis. 168:84-91.
291. Nottet, H. S. M. L., and H. E. Gendelman. 1995. Unravelling the neuroimmune mechanisms for the HIV-1 associated cognitive/motor complex. Immunol. Today 16:441-448.
292. Nye, K. E., and A. J. Pinching. 1990. HIV infection of H9 lymphoblastoid cells chronically activates the inositol phosphate pathway. AIDS 4:41-45.
293. Nye, K. E., G. A. Riley, and J. Pinching. 1992. The defect seen in the PI hydrolysis pathway in HIV infected lymphocytes and lymphoblastoid cells is due to inhibition of the 1,4,5-trisphosphate 1,3,4,5-tetrakisphosphate 5-phosphomonoesterase. Clin. Exp. Immunol. 89:89-93.
294. Nygren, A., T. Bergman, T. Mathews, H. Jornvall, and H. Wigzell. 1988. 95 and 25 kDa fragments of the HIV envelope glycoproteins gp120 bind to the CD4 molecule. Proc. Natl. Acad. Sci. USA 85:6543-6546.
295. Oh, S.-Y., W. W. Cruickshank, J. Raina, G. C. Blanchard, W. H. Adler, J. Walker, and H. Kornfeld. 1992. Identification of HIV-1 envelope glycoprotein in the serum of AIDS and ARC patients. J. Acquired Immune Defic. Syndr. 5:251.
296. O'Haughn, L., S. Gratton, L. Caron, R.-P. Sekaly, A. Veillette, and M. Julius. 1992. Association of tyrosine kinase p561ck with CD4 inhibits the induction of growth through the alpha-beta T cell receptor. Nature (London) 358:328-334.
297. Oldstone, M. B. A. 1987. Molecular mimicry and autoimmune disease. Cell 50:819-820.
298. Olive, D., and C. Mawas. 1993. Therapeutic applications of anti-CD4 antibodies. Crit. Rev. Ther. Drug Carrier Syst. 10:29-63.
299. Oravecz, T., and M. A. Norcross. 1993. Costimulatory properties of human CD4 molecules: enhancement of CD3-induced T cell activation by HIV-1 through viral envelope glycoprotein, gp120. AIDS Res. Hum. Retroviruses 9:945-955.
300. Oravecz, T., G. Roderiquez, J. Koff, J. Wang, M. Ditto, D. C. Bou-Habib, P. Lusso, and M. A. Norcross. 1995. CD26 expression correlates with entry replication and cytopathicity of monocytotropic HIV-1 strains in a T cell line. Nat. Med. 1:919-926.
301. ++ influx or lead to activation of protein kinases. AIDS Res. Hum. Retroviruses 7:587-593.
302. + T lymphocytes by inhibiting interleukin 2 mRNA. Proc. Natl. Acad. Sci. USA 87:2379-2383.
303. + T-cell clones. J. Virol. 65:6277-6282.
304. Oyaizu, N., N. Chirmule, and S. Pahwa. 1992. Role of CD4 molecule in the induction of interleukin 2 and interleukin 2 receptor in major histocompatibility complex restricted antigen-specific T helper clones: T cell receptor/CD3 complex transmits CD4-dependent and CD4-independent signals. J. Clin. Invest. 89:1807-1816.
305. Oyaizu, N., T. McCloskey, M. Coronesi, N. Chirmule, V. S. Kalyanaraman, and S. Pahwa. 1993. Accelerated apoptosis in peripheral blood mononuclear cells from HIV infected patients and in CD4 cross-linked PBMC from normal individuals. Blood 82:3392-3400.
306. Oyaizu, N., T. McCloskey, V. S. Kalyanaraman, M. Coronesi, and S. Pahwa. 1994. Crosslinking of CD4 molecules upregulates fas antigen expression in lymphocytes by inducing interferon gamma and tumor necrosis factor alpha. Blood 84:2622-2631.
307. Oyaizu, N., and S. Pahwa. 1995. Role of apoptosis in HIV disease pathogenesis. J. Clin. Immunol. 15:217-231.
308. Pahwa, S. 1988. HIV infection in children: nature of immune deficiency: clinical spectrum and management. Pediatr. Infect. Dis. J. 7:S61-S71.
309. Pahwa, S., R. Pahwa, R. A. Good, R. C. Gallo, and C. Saxinger. 1986. Stimulatory and inhibitory influences of human immunodeficiency virus on normal B lymphocytes. Proc. Natl. Acad. Sci. USA 83:9124-9128.
310. Pal, R., B. C. Nir, G. M. Hoke, M. G. Sarngadharan. and M. Edidin. 1991. Lateral diffusion of CD4 on the surface of a human neoplastic T cell line probed with a fluorescent derivative of the envelope glycoprotein gp120 of HIV-1. J. Cell. Physiol. 147:326-332.
311. Pandolfi, F., A. Pierdominici, A. Oliva, G. D'Offizi, I. Mezzaroma, B. Mollicone, A. Giovannetti, L. Rainaldi, I. Quinti, and F. Aiuti. 1995. Apoptosis related mortality in vitro of mononuclear cells from patients with HIV infection correlates with disease severity and progression. J. Acquired Immune Defic. Syndr. 9:450-458.
312. + T cells with a predominant Vb usage in the primary immune response to HIV. Nature (London) 370:463-467.
313. Parker, D. C. 1993. T-cell-dependent B-cell activation. Annu. Rev. Immunol. 11:331-360.
314. Perlmutter, R. M., S. D. Levin, M. W. Appleby, S. J. Anderson, and J. A. Ila. 1993. Regulation of lymphocyte function by protein phosphorylation. Annu. Rev. Immunol. 11:451-499.
315. Peters, A. M., F. S. Jager, A. Wareneke, K. Muller, U. Brunkhosrt, I. Schedel, and M. Ghar. 1991. Cytokine secretion by peripheral blood monocytcs from HIV-infected patients was normal. Clin. Immunol. Immunopathol. 61:343-352.
316. Peterson, A., and B. Seed. 1988. Genetic analysis of mAb and HIV binding sites on human lymphocyte antigen CD4. Cell 54:65-72.
317. Petit, A. J. C., M.Tersmette, F. G. Terpstra, R. E. Y. de Goede, R. A. W. van Lier, and F. Miedema. 1988. Decreased accessory cell function with human monocytic cells after infection with HIV. J. Immunol. 140:1485-1489.
318. Phillips, D. 1994. The role of cell-to-cell transmission in HIV infection. AIDS 8:719-731.
319. Pietraforte, D., E. Tritarelli, U. Testa, and M. Minetti. 1994. gp120 HIV envelope glycoprotein increased the production of nitric oxide in human monocyte-derived macrophages. J. Leukocyte Biol. 55:175-182.
320. Pinching, A. J.. and K. E. Nye. 1991. Defective signal transduction: a common pathway for cellular dysfunction in HIV infection? Immunol. Today 11:256-259.
321. Posnett, D., S. Kabak, A. S. Hodtsev, E. A. Goldberg, and A. Asch. 1993. T cell antigen receptor Vβ subsets are not perferentially deleted in AIDS. AIDS 7:625-631.
322. lck complex: the p56lck SH3 domain binds to PI 3-kinase but not to PI 4-kinase. Mol. Cell. Biol. 13:7708-7717.
323. lck complex in T cells. Mol. Cell. Biol. 12:5260-5267.
324. Pulliam, L., D. West, N. Haigwood, and R. A. Swanson. 1993. HIV-1 envelope protein gp120 alters astrocytes in human brain cultures. AIDS Res. Hum. Retroviruses 5:439-444.
325. Radrizzani, M., P. Accornero, A. Amidei, A. Aiello, D. Delia, R. Kurrle, and M. P. Colombo. 1995. IL-12 inhibits apoptosis induced in a human Th1 clone by gp120/CD4 cross-linking and CD3-TCR activation or by IL-2 deprivation. Cell. Immunol. 161:14-21.
326. + cells, but markedly decreased helper cell activity in mice lacking CD4. Nature (London) 353:180-184.
327. Ramsdell, F., and B. J. Fowlkes. 1989. Engagement of CD4 and CD8 accessory molecules is required for T cell maturation. J. Immunol. 143:1467-1471.
328. Rautonen, J., N. Rautonen, N. L. Martin, and D. W. Wara. 1994. HIV-1 tat protein induces immunoglobulin and interleukin 6 synthesis by uninfected peripheral blood mononuclear cells. AIDS Res. Hum. Retroviruses 10:781-785.
329. +) cells purified from the bone marrow of AIDS patients are committed to apoptotic cell death in culture. AIDS 7:1049-1055.
330. + T cells of the virus positive twins. Proc. Natl. Acad. Sci. USA 91:1529-1533.
331. Reiher, W, E., J. E. Blalock, and T. K. Brunck. 1986. Sequence humoloy between AIDS virus envelope protein and interleukin 2. Proc. Natl Acad Sci. USA 83:9188-9192.
332. Robbins, D., Y. Shirazi, B. E. Drysdale, A. Lieberman, H. S. Shin, and M. L. Shin. 1987. Production of cytotoxic factors for oligodendrocytes by stimulated astrocytes. J. Immunol. 139:2593-2397.
333. Robey, E., and R. Axel. 1990. CD4: collaborator in immune recognition and HIV infection. Cell 60:697-700.
334. Robey, E., and B. J. Fowlkes. 1994. Selective events in T cell development Annu. Rev. Immunol. 12:675-705.
335. Romagnani, S. 1994. Lymphokine production by human T cells in disease states. Annu. Rev. Immunol. 12:227-257.
336. Rosenstein, Y., S. J. Burakoff, and S. H. Herrmann. 1990. HIV-gp120 can block CD4-MHC class II mediated adhesion. J. Immunol. 144:526-531.
337. Ruegg, C. L., C. R. Monell, and M. Strand. 1989. Inhibition of lymphoproliferation by a synthetic peptide with sequence identity to gp41 of human immunodeficiency virus type 1. J. Virol. 63:3257-3260.
338. Rusche, J., K. Jhaverian, C. McDanal, J. Petro, D. L. Lynn, R. Grimala, A. Langlois. R. C. Gallo, L. O. Arthur, P. J. Fischinger, D. P. Bolognesi, S. D. Putney, and T. J. Mathews. 1988. Antibodies that inhibit fusion of HIV-infected cells bind a 24 amino acid sequence of the viral envelope gp120 Proc. Natl. Acad. Sci. USA 85:3198-3202.
339. Ryu, S. E., P. D. Kwong, A. Truneh, T. G. Porterm, J. Arthos, M. Rosenberg, X. Dai, N. Xuong, R. Axel, R. W. Sweet, and W. A. Hendricksen. 1990. Crystal structure of an HIV binding recombinant fragment of human CD4. Nature (London) 348:419-421.
340. Salmon, M. D., D. Pilling, N. J. Borthwick, N. Viner, G. Jonnosy, P. A. Bacon, and A. N. Akbar. 1994. The progressive differentiation of primed T cells is associated with an increasing susceptibility to apoptosis. Eur. J. Immunol. 24:892-902.
341. Sattentau, Q. J. 1992. CD4 activation of HIV fusion. Int. J. Cloning 10:6323-6332.
342. Sattentau, Q. J., and J. P. Moore. 1993. The role of CD4 in HIV binding and entry. Philos. Trans. R. Soc. London Ser. B 342:59-66.
343. Sehneider, J., O. Khaaden, T. D. Copeland, S. Oroszlan, and G. Huns-mann. 1986. Shedding and interspecies type sero-reactivity of the envelope glycoprotein gp120 of the human immunodeficiency virus. J. Gen. Virol. 67:2533-2538.
344. Schneider, J., S. Schaulies, R. Brinkmann, P. Tas, M. Halbugge, V. Walter, H. C. Holmes, and V. T. Mulen. 1992. HIV-1 gp120 receptor on CD4 negative brain cells activates a tyrosine kinase. Virology 191:765-772.
345. Schnittman, S., S. M. Denning, J. J. Greenhouse, J, S. Justement, M. Maseler, J. Kurtzbergm, B. F. Haynes, and A. S. Fauci. 1990 Evidence of susceptibility to intrathymic T cell precursors for their progeny carrying T cell antigen receptor phenotypes TCR ab and gd to HIV infection: a mechanism for CD4 (T4) lymphocyte depletion. Proc. Natl. Acad. Sci. USA 87:7727-7731.
346. Schnittman, S., C. Psallidopolous, H. C. Lane, L. Thompson, M. Bassler.F. Massari, C. H. Fox, N. P. Salzman, and A. S. Fauci. 1989. The reservoir for HIV-1 in human peripheral blood is a T cell that maintains expression of CD4. Science 245:305-308.
347. Schnittman, S. M., H. L. Clifford, S. Higgins, T. Folks, and A. S. Fand. 1986. Direct polyclonal activation of human B lymphocytes by acquired immunodeficiency virus. Science 233:1084-1086.
348. Schnittman, S. M., and A. S. Fauci. 1994. HIV and AIDS: an update. Adv. Intern. Med. 39:305-355.
349. Schooley, R. T., T. C. Merrigan, P. Gaut, M. Hirsch, M. Holodny, T. Flynn, S. Liu, B. Byington, B. S. Henochowicz, E. Gubish, D. Spriggs, D. Kuffe, J. Schidler, A. Dawson, D. Thomas, D. Hanson, B. Letwin, T. Liu, J. Gulinello, S. Kennedy, R. Fisher, and D. Ho. 1990. Recombinant soluble CD4 therapy in patients with AIDS and ARC. Ann. Intern. Med. 112:247-253.
350. + lymphocytes after contact with membrane-bound HIV-1 envelope glycoprotein. Virology 198:360-365.
351. Schwartz, R. H. 1990. A cell culture model for T lymphocyte clonal anergy. Science 248:1349-1356.
352. Selmaj, K. W., M. Farooq, W. T. Norton, C. S. Raine, and C. F. Bronsan. 1990. Proliferation of astrocytes in vitro in response to cytokine: a primary role for TNF. J. Immunol. 144:129-135.
353. Shalaby, M. R., J. K. Krowka, T. J. Gregory, S. E. Hirabayashi, S. M. McCabe, D. S. Kaufman, D. P. Stites, and A. J. Ammann. 1987. The effects of HIV recombinant envelope glycoproteins on immune cell functions in vitro. Cell. Immunol. 110:140-148.
354. Shearer, G. M., and M. Clerici. 1993. Abnormalities of immune regulation in HIV infection. Pediatr. Res. 33:S71-S75.
355. Shi, T., J. M. Glynn, L. G. Guilbert, T. G. Cotter, R. P. Bissonnette, and D. R. Green. 1992. Role of c-myc in activation-induced apoptotic cell dealt in T cell hybridomas. Science 257:212-214.
356. Shioda, T., J. A. Levy, and C. Cheng-Mayer. 1991. Macrophage and T cell line trophism of HIV-1 are determined by specific regions of the envelope gp120 gene. Nature (London) 349:167-169.
357. Shiratsuchi, H., J. L. Johnson, Z. Toossi, and J. J. Ellner. 1994. Modulation of the effector function of human monocytes for M. avium by IIIV-1 envelope glycoprotein gp120. J. Clin. Invest. 93:885-891.
358. Sica, A., T. H. Tan, N. Rice, M. Kretzschmar, P. Ghosh, and H. A. Young. 1992. The c-rel proto-oncogene product C-Rel, hut not NF-κB binds to the intronic region of the human interferon gamma gene at a site related to an interteron-stimulable response element. Proc. Natl. Acad. Sci. USA 89:1740-1744.
359. Silerstris, F., R. C. Williams, and F. Dammacco. 1995. Autoreactivity in HIV-1 infection: role of molecular mimicry. Clin. Immunol. Immunopathol. 75:197-205.
360. Sloan-Lancaster, J., A. S. Shaw, J. B. Rothbard, and P. M. Allen. 1994. Partial T cell signalling: altered phospho zeta and lack of Zap70 recruitment in APL-induced T cell anergy. Cell 79:913-922.
361. Sodroski, J., W. C. Goh, C. Rosen, K. Campbell, and W. A. Haseltine. 1986. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity. Nature (London) 332:470-474.
362. Solder, B., T. F. Schulz, P. Hengster, J. Lower, C. Larcher, G. Bitterlich, R. Kurth, H. Wachter, and M. P. Dierich. 1989. HIV and HIV-infectcd cells differently activate the human complement system independent of antibody. Immunol. Lett. 22:135-146.
363. Soliven, B., and J. Albert. 1992. TNF modulates calcium currents in cultured sympathetic neurons. J. Neurosci. 12:2665-2671.
364. Soliven, B., M. Takeda, and S. Szuchet. 1994. Depolarizing agents and TNF alpha modulate protein phosphorylation in oligodendrocytes. J. Neurosci. Res. 38:91-100.
365. Soudens, H., N. Rebai, G. P. Pantaleo, C. Ciurli, T. Boghossian, R.-P. Sekaly, and A. S. Fauci. 1993. The T cell receptor Vb repertoire in HIV-1 infection and disease. Semin. Immunol. 5:175-185.
366. Soudens, H., J. P. Routy, and R.-P. Sekaly. 1994. Comparative analysis of the T cell receptor V beta repertoire in various lymphoid tissues from HIV-intected patients: evidence for an HIV-associated superantigen. Leukemia 8:S95-S97.
367. Soula, M., R. Fagard, R., and S. Fisher. 1992. Interaction of human immunodeficiency virus glycoprotein 160 with CD4 in Jurkat cells increases p5h lck autophosphorylation and kinasc activity. Int. Immunol. 4:295-299.
368. Sperber, K., G. Hamrang, M. J. Louie, T. Kalb, R. Banerjee, H. S. Choi, F. Paronetto, and L. Mayer. 1993. Progressive impairment oi monocytic function in HIV-1 infected human macrophage hyhridomas. AIDS Res. Hum. Retroviruses 9:657-667.
369. Spivak, J. L., B. S. Bender, and T. C. Quinn. 1984. Hematologic abnormalities in AIDS, Am. J. Med. 77:224-228.
370. Srinivas, S., R. V. Srinivas, G. M. Anantharamaiah, R. W. Compans, and J. P. Segrest. 1993. Cytosolic domain of HIV envelope glycoprotein binds to calmodulin and inhibits calmodulin regulated proteins. J. Biol. Chem. 268:22895-22899.
371. Staal, F. J. T., S. W. Ela, M. Roederer, M. T. Andersen, L. A. Herzenberg, and L. A. Herzenberg. 1992. Glutathione deficiency and HIV infection. Lancet 339:909-912.
372. Stamatatos, L., and C. Cheng-Mayer. 1993. Evidence that the structural conformation of envelope gp120 affects human immunodeficiency virus type 1 infectivity host range and syncytiurn formation ability. J. Virol. 67:5635-5639.
373. + bone marrow cells are infected with HIV in a subset of seropositive progenitors. J. Acquired Immune Defic. Syndr. 4:689-697.
374. Stanley, S. K., J. McCune, H. Kaneshima, M. Sullivan, E. Boone, M. Baseler, J. Adelsberger, M. Bonyhadi, J. Orenstein, and A. S. Fauci. 1993. HIV infection of the human thymus and disruption of the thymic micro-environment in SCID-hu mouse. J. Exp. Med. 178:1151-1163.
375. Stella, C. C., A. Ganser, and D. Hoelser. 1987. Defective in vitro growth of hematopoietic progenitor cells in the acquired immundeficiency syndrome. J. Clin. Invest. 80:286-293.
376. Sterrer, H. 1995. Mechanism and genes of cellular suicide. Science 267:1445-1449.
377. Stewart, S. J., J. Fujimoto, and R. J. Levy. 1986. Human T lymphocytes and monocytes beat the same Leu3 (T4) antigen. J. Immunol. 136:3773-3778.
378. Stroiber, H., C. Ebenbichler, R. Schneider, J. Janatova, and M. P. Dierich. 1995. Interaction of several complement proteins with gp120 and gp41, the two envelope glycoproteins of HIV-1. AIDS 9:19-26.
379. Stroiber, H., C. Ebenbichler, N. Thielens, G. J. Arlaud, and M. P. Dierich. 1995. HIV-1 gp41 dependent on calcium for binding of human C1q hut not for binding of gp120. Mol. Immunol. 32:371-374.
380. Su, L., H. Kaneshima, M. Bonyhadi, S. Salimi, D. Kraft, L. Rabin, and J. M. McCune. 1995. HIV-1 induced thyocyte depletion is associated with indirect cytopathicity and infection of progenitor cells in vivo. Immunity 2:25-36.
381. Suiguira, K., N. Oyaizu, V. S. Kalyanaraman, and S. Pahwa. 1992. Effects of human immunodeficiency virus type I envelope glycoprotein gp160 on in vitro hematopoiesis of umbilical cord blood. Blood 80:1463-1469.
382. Susal, C., M. Kirschfink, M. Kropelin, V. Daniel, and G. Opelz. 1994. Complement activation by recombinant HIV-1 glycoprotein. gp120. J. Immunol. 152:6028-6034.
383. Szawlowski, P. W., T. Hanke, and R. E. Randall. 1993. Sequence homology between HIV-1 gp120 and the apoptosis mediating protein Fas. AIDS 7:1018.
384. Takahashi, T., M. Tanaka, C. I. Brannan, N. A. Jenkins, N. G. Copeland, T. Suda, and S. Nagata. 1994. Generalized lymphoproliferative disease in mice caused by a point mutation in the Fas ligand. Cell 76:969-976.
385. Tamma, S. L. Unpublished data.
386. Tanaka, K. E., W. C. Hatch, V. Kress, R. Soeiro, T. Calvelli, W. K. Rash-baum, A. Runenstein, and W. D. Lyman. 1992. HIV-1 infection of human fetal thymocytes. J. Acquired Immune Defic. Syndr. 5:94-101.
387. Telfer, J. C., and C. E. Rudd. 1991. A 32 kD GTP binding protein associated with CD4-p56lck and CD8 p56lck T cell receptor complexes. Science 254:439-441.
388. Terai, C., R. S. Kornbluth, C. D. Pauza, D. D. Richman, and D. A. Carson. 1991. Apoptosis as a mechanism of cell death in cultured T lymphoblasts acutely infected with HIV-1. J. Clin. Invest. 87:1710-1715.
389. Terpstra, F. G., B. J. L. Al, M. T. L. Roos, F. De Wolf, J. Goudsmit, P. T. A. Schellekens, and F. Meidema. 1989. Longitudinal study of leukocyte functions in homosexual men seroconverted for HIV: rapid and persistent loss of B cell function after HIV infection. Eur. J. Immunol. 19:667-673.
390. Than, S., N. Oyaizu, V. S. Kalyanaraman, and S. Pahwa. 1994. Effects of human immunodeficiency virus type 1 envelope glycoprotein gp160 on cytokine production from cord blood T cells. Blood 84:184-188.
391. Theilens, N, C., I. Bally, C. F. Ebenbichler, M. P. Dierich, and G. Arlaud. 1993. Ca binding properties and Ca dependent interaction between C1q subcomponent of the human C1 and the transmembrane envelope glycoprotein. gp41. J. Immunol. 151:6583-6592.
392. Theilens, N. C., C. Illy, I, Bally, and G. J. Arlaud. 1994. Activation of human complement serine proteinase clr is down regulated by a calcium dependent intramolecular control that is released in the C1 complex through a signal transmitted by C1q. Biochem. J. 301:509-516.
393. Theodore, A., H. Kornfeld, R. P. Wallace, and W. W. Cruiekshank. 1994. CD4 modulation of noninfected human T lymphocytes by HIV-1 envelope glycoprotein gp120: contribution to immunosuppression seen in HIV-1 infection by induction of CD4 and CD3 unresponsiveness. J. Acquired Immune Defic. Syndr. 7:899-907.
394. Thiebblemont, N., N. H. Cabaillon, L. Weiss, F. Malliet, and M. D. Kazatchkine. 1993. Complement activation of gp160 glycoprotein of HIV-1. AIDS Res. Hum. Retroviruscs 9:229-233.
395. Thompson, C. B. 1995. Apoptosis in the pathogenesis and treatment of disease. Science 267:1456-1462.
396. Toggas, S. M., E. Masliah, E. M. Rockenstein, G. F. Rall, C. R. Abraham, and L. Mucke. 1994. CNS damage produced by expression of HIV coat protein in transgenic mice. Nature (London) 367:188-193.
397. Tremblay, M., K. Numazaki, H. Goldman, and M. A. Wainberg. 1990. Infection of human thymic lymphocytes by HIV-1 J. Acquired Immune Defic. Syndr. 3:356-360.
398. Tsygankov, A., B. M. Broker, A. H. Guse, V. Meinke, E. Roth, C. Rossmann, and F. Emmrich. 1994. Preincubation with anti-CD4 influences activation of human T cells by subsequent co-cross-linking of CD4 with CD3. J. Leukocyte Biol. 54:430-438.
399. Ullman, K. S., J. P. Northrop, C. L. Verweij, and G. R. Crabtree. 1990. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: the missing link. Annu. Rev. Immunol. 8:421-452.
400. Umlauf, S. W., B. Beverly, S.-M. Kang, K. Bronson, A.-C. Tran, and R. H. Schwartz. 1993. Molecular regulation of the IL-2 gene: rheostatic control of the immune system. Immunol. Rev. 133:177-197.
401. Vaux, D. L. 1993. Toward an understanding of the molecular mechanisms of physiological cell death. Proc. Natl. Acad. Sci. USA 90:786-789.
402. Vaux, D. L., G. Haecker, and A. Strasser. 1994. An evolutionary perspective on apoptosis. Cell 76:777-779.
403. + hematopoietic progenitor cells are not a major reservoir of HIV. Blood 76:1281-1286.
404. Wahl, S. M., J. B, Allen, S. Gartner, J. M. Orenstein, M. Popovic, D. E. Chenoweth, L. O. Arthur, W, L. Farrar, and L. M. Wahl. 1989. HIV-1 and its envelope glycoprotein down regulate chcrnotactic ligand receptors and chemotactic function of peripheral blood monocytes. J. Immunol. 142:3553-3559.
405. Wahl, L. M., M. L. Corcoran, S. W. Pyle, L. O. Arthur, A. H. Bellan, and W. L. Farrar. 1989. Human immunodeficiency virus glycoprotein (gp120) induction of monocyte arachidortic acid metabolites and interleukin 1. Proc. Natl. Acad. Sci. USA 86:621-625.
406. Wang, H., P. Nishanian, and J. L. Fahey. 1995. Characterization of immune suppression by a synthetic HIV gp41 peptide. Cell, immunol. 161:230-243.
407. Wang, J., Y. Van, T. P. J. Garret, J. Liu, D. W. Rodgers, R. L. Garlick, G. E. Tarr, Y. Husain, E. L. Reinherz, and S. C. Harrison. 1990. Atomic structure of a fragment of human CD4 containing two immunoglobulin-like domains. Nature (London) 348:411-419.
408. Wang, Z.-Q., A. Dudhane, T. Orlikowsky, K. Clarke, X. Li, Z. Darzynkiewicz, and M. K. Hoffman. 1994. CD4 engagement induces Fas antigen-dependent apoptosis on T cells in vivo. Eur. J. Immunol. 24:1549-1552.
409. Wang, Z.-Q., T. Orlikowsky, A. Dudhane, R. Mittler, M. Blum, E. Lacy, G. Reithmuller, and M. K. Huffman. 1994. Deletion of T lymphocytes in human CD4 transgenic mice induced by HIV-gp120 and gp120-specific antibodies from AIDS patients. Eur. J. Immunol. 24:1553-1557.
410. Watanabe-Fukunaga, R., C. I. Brannan, N. G. Copeland, N. A. Jenkins, and S. Nagata. 1992. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature (London) 356:314-317.
411. Weber, G. F., and H. Cantor. 1993. HIV glycoprotein as a superantigen. A mechanism of autoimmunity and implications for a vaccination strategy. Med. Hypotheses 41:247-250.
412. Wei, X., S. K. Ghosh, M. E. Taylor, V. A. Johnson, E. A. Emini, P. Deutsch, J. D. Lifson, S. Bonhoeffer, M. A. Nowak, B. H. Hahn, M. S. Saag, and G. M. Shaw. 1995. Viral dynamics in human immunodeficiency virus type 1 infection. Nature (London) 373:117-122.
413. Weinhold, K., H. K. Lyerly, S. D. Stanley, A. A. Austin, T. J. Mathews, and D. P. Bolognesi. 1989. HIV-1 gp120-mediated immune suppression and lymphocyte destruction in the absence of viral infection. J. Immunol. 142:3091-3097.
414. Weiss, A., and D. R. Littman. 1994. Signal transduction by lymphocyte antigen receptors. Cell 76:263-274.
415. Weiss, R. A. 1992. Human immunodeficiency virus receptors. Semin. Virol. 3:79-84.
416. Westendorf, M. O., R. Frank, C. Ochsenbauer, K. Striker, J. Dhein, H. Walczak, K.-M. Debatin, and P. H. Krammer. 1995. Sensitization of T cells to Cd95 mediated apoptosis by HIV-1 tat and gp120. Nature (London) 375:497-500.
417. Wolf, H., Y. Muller, S. Salmen, W. Wilmanns, and G. Jung. 1994. Induction of anergy in resting human T lymphocytes by immobilized anti-CD3 antibodies. Eur. J. Immunol. 24:1410-1417.
418. Woronicz, J. D., B. Cianan, V. Ngo, and A. Winito. 1994. Requirement of the orphan steroid receptor Nur77 apoptosis of T cell hybridomas. Nature (London) 367:277-279.
419. Wyllie, A. H., R. G. Morris, A. L. Smith, and D. Dunlop. 1991. Chromatic cleavage in apoptosis: association with condensed rhromatin morphology and dependence on macromolecular synthesis. J. Pathol, 142:67-77.
420. Wylley, C. A., R. D. Schreier, J. A. Nelson, P. W. Lambert, and M. B. A. Oldstone. 1986. Cellular localization of HIV infection with brain of AIDS patients. Proc. Natl. Acad. Sci. USA 83:7089-7093.
421. Yamashita, T., and D. L. Boros. 1990. Changing patterns of lymphocyte proliferation. IL-2 production and utilization, and IL-2 receptor expression in mice infected with Schistosoma mansoni. J. Immunol. 144:725-731.
422. Yarchoan, R., R. R. Redfield, and S. Broder. 1986. Mechanisms of B cell activation in patients with acquired immunodeficiency syndrome and related disorders. J. Clin. Invest. 78:439-447.
423. Yeung, M. C., L. Pulman, and A. S. Lau. 1995. The HIV envelope protein gp120 is toxic to human brain cell cultures through the induction of IL-6 and TNF-α. AIDS 9:137-143.
424. Yonehara, S., A. Ishi, and M. Yonehara. 1989. A cell killing monoclonal antibody (anti-fas) to a cell surface antigen codownmodulated with the receptor for tumor necrosis factor. J. Exp. Med. 169:1747-1756.
425. Yoshida, H., K. Kaga, Y. Moroi, G. Kimura, and K. Momoto. 1992. The effect of p56 lck, a lymphocyte specific protein tyrosine kinase. on syncytium formation by HIV envelope glycoprotein. Int. Immunol. 4:233-242.
426. Zagury, J. F., J. Bernard, A. Achour, A. Astgen, A. Lachgar, L. Fall, C. Carelli, W. Issing, J. P. Mbika, and D. Picard. 1993. Identification of CD4 and MHC functional peptide sites and their homology with oligopeptida from HIV-1 gp120: role in AIDS pathoegenesis. Proc. Natl. Acad. Sci. USA 90:7573-7577.
427. Zagury, J. F., H. Cantaloube, J. Bernard, J. P. Mornon, B. Bizzini, and B. Zagury. 1992. Striking similarities between HIV-1 envelope glycoprotein gp120 and its CD4 receptor. Lancet 340:483-484.
428. Zambruno, G., L. Mori, A. Marconi, N. Mongiardi, B. De Reinzo, U. Bertazzoni, and A. Giannetti. 1991. Detection of HIV-1 in epidermal Langerhan cells of HIV-infected patients using the polymerase chain reaction. J. Invest. Dermatol. 96:979-982.
429. ++ levels. Microbiologica 17:85-92.
430. + hematopoietic progenitors in human immunodeficiency virus type 1 seropositive thrombocytopenic individuals. Blood 79:2680-2687.
431. + cells). J. Gen. Vitol. 73:417-421.
432. + hematopoietic progenitor cells. Arch. Virol. 122:271-280.
433. +) cells in AIDS patients. J. Infect. Dis. 166:710-716.
434. Zembala, M., J. Prujma, A. Plucienniczak, A. Szczepanek, M. Jasinski, I. Ruggiero, P. Piselli, and V. Colizzi. 1995. Interaction of HIV-1 gp120 molecule fragments with human monocytcs: different requirements for tumor necrosis factor and IL-6 production. Clin. Immunol. Immunopathol 75:131-139.
435. Zinkernagel, R. M. 1995. Are HIV specific CTL responses salutary W pathogenic? Curr. Opin. Immunol. 7:462-470.
436. Zolla-Pazner, S., and M. K. Gorny. 1992. Passive immunization for the prevention and treatment of HIV infection. AIDS 6:1235-1247.
437. Zorn, N. E., C. L. Weill, and D. H. Russel. 1990. The HIV protein gp120 activates nuclear protein kinase C in nuclei from lymphocytes and brain. Biochem. Biophys. Res. Commun. 166:1133-1139.